Vistagen Therapeutics, Inc.
fasedienol
social anxiety disorder
Resolved
7days ago
Phase 3 readout · Jun 30, 2026
What's at stake
Phase 3 trial results for fasedienol in social anxiety disorder are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol Topline Results Tuesday, June 30, 2026 8:30 a.m. EST”